Netzsch removes risk from process scaling

Published: 16-Nov-2010
Manufacturing

LabStar multi-functional mill can be scaled-up to comparable production machines

Netzsch Mastermix, part of Netzsch Group’s grinding and dispersing business unit, has developed the LabStar Pilot/Laboratory bead mill, which is the smallest grinding mill in its portfolio.

The company says the LabStar can be directly scaled up to its larger cousins in the Netzsch bead mill range.

Configurable as a Zeta peg milling system or as a TriNex disc milling system, LabStar replicates all of the possible combinations and applications that are encountered by full-size production mills.

Available in a range of materials, and ATEX certified, the Lichfield, UK-based firm says there is a configuration to match any production situation that needs to be accurately defined at a pilot scale.

  • Companies:
  • Netzsch Group
See more

You may also like

Manufacturing

Fine granulation and greater efficiency

Read more
Until recently, achieving fine granulation meant lower productivity. Andy James, at Netzsch Mastermix, argues that with high density bed jet mills this is no longer the case

Trending Articles

  1. Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025 The company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation behaviour in small-molecule development
  2. Merck Life Science announces closure of Arklow facility Merck has said it will close the plant in Co Wicklow, Ireland, by the end of 2028, with the loss of 100 jobs
  3. Aseptic spray drying: Transforming biotherapeutics for a new era With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications
  4. Hovione completes $100m investment cycle for expansion of US manufacturing campus The investment into the New Jersey facility will more than double capacity for spray drying
  5. What to expect from a regulatory inspection NSF’s expert guide outlines key expectations, common pitfalls and strategies for lasting inspection readiness

You may also like

Manufacturing

Fine granulation and greater efficiency

Until recently, achieving fine granulation meant lower productivity. Andy James, at Netzsch Mastermix, argues that with high density bed jet mills this is no longer the case
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part III)

The third instalment from the CPHI Frankfurt show floor explores practical approaches and fresh perspectives on scale-up, tech transfer, and manufacturing innovation across the pharmaceutical sector
Manufacturing

Streamlining bioconjugation for next-generation ADC development

Abzena’s proprietary ThioBridge™ technology delivers precision, scalability, and enhanced stability for antibody-drug conjugates
Manufacturing

OPTIMA machinery USA Corporation marks 40 years of growth and innovation in the US

OPTIMA machinery USA Corporation, a subsidiary of the German-based OPTIMA Packaging Group, is celebrating 40 years of successful operations in the United States
Manufacturing

How to execute a successful remediation strategy

NSF’s experts share guidance on building sustainable compliance and avoiding quick fixes
Manufacturing

How to optimise your quality culture and maturity for success

NSF outlines how aligning culture, leadership and systems can strengthen compliance and performance
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part II)

Industry leaders at CPHI Frankfurt are embracing emerging technologies — including automation, AI, advanced analytics and innovative manufacturing platforms — to drive efficiency, quality, scalability and sustainability in pharmaceutical production and development
Subscribe now